代谢网络改变作为多巴胺转运保留的路易体痴呆的支持性生物标志物
本研究对无显著多巴胺缺乏的很可能或可能路易体痴呆(DLB)患者(n=22)进行FDG-PET分析,并与健康对照(n=23)及有多巴胺缺乏的DLB患者(n=86)比较。结果显示两组DLB患者均呈现相似的代谢减低(顶叶和枕叶皮层)和代谢增高(基底节、边缘系统、运动皮层)模式,代谢连接改变相关(R²=0.597,p<0.01)。基于主成分分析(PCA)的分类器在个体患者水平区分无显著多巴胺损失的DLB与其他神经退行性帕金森综合征的AUC为0.912。
要点
- 无显著多巴胺缺乏的DLB患者仍存在疾病特异性葡萄糖代谢模式和代谢网络改变。
- FDG-PET代谢网络改变可在症状发作时无显著多巴胺损失的DLB亚组中作为支持性生物标志物。
- PCA分类器在个体水平区分无显著多巴胺损失的DLB与其他神经退行性帕金森综合征的AUC为0.912。
核心结论
- 疾病特异性的葡萄糖代谢改变和代谢网络改变存在于无显著多巴胺能损失的DLB受试者中。
- FDG-PET中的代谢网络改变可在症状发作时无显著多巴胺能损失的DLB患者亚组中作为支持性生物标志物。
研究设计与样本
- 本研究为FDG-PET代谢网络分析研究,纳入很可能或可能DLB且无显著多巴胺缺乏(纹状体壳核结合损失z-score<2,与健康对照相比,DaT-SPECT)的受试者n=22。
- 比较对象为健康对照(n=23)和有多巴胺缺乏的DLB受试者(n=86),并应用主成分分析(PCA)在个体患者水平测试DLB与疾病对照(n=101)的区分。
主要发现
- 与健康对照相比,有无显著多巴胺缺乏的DLB患者均观察到相似的代谢减低(顶叶和枕叶皮层)和代谢增高(基底节、边缘系统、运动皮层)模式。
- 有无显著多巴胺缺乏的DLB患者之间的代谢连接改变相关(R²=0.597,p<0.01)。
- 由有多巴胺缺乏的DLB患者和健康对照训练的主成分分析在个体患者水平区分无显著多巴胺能损失的DLB与其他神经退行性帕金森综合征,曲线下面积(AUC)为0.912。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Metabolic network analysis of FDG-PET utilizes an index of inter-regional correlation of resting state glucose metabolism and has been proven to provide complementary information regarding the disease process in parkinsonian syndromes. The goals of this study were (i) to evaluate pattern similarities of glucose metabolism and network connectivity in dementia with Lewy bodies (DLB) subjects with subthreshold dopaminergic loss compared to advanced disease stages and to (ii) investigate metabolic network alterations of FDG-PET for discrimination of patients with early DLB from other neurodegenerative disorders (Alzheimer's disease, Parkinson's disease, multiple system atrophy) at individual patient level via principal component analysis (PCA). METHODS: FDG-PETs of subjects with probable or possible DLB (n = 22) without significant dopamine deficiency (z-score < 2 in putamen binding loss on DaT-SPECT compared to healthy controls (HC)) were scaled by global-mean, prior to volume-of-interest-based analyses of relative glucose metabolism. Single region metabolic changes and network connectivity changes were compared against HC (n = 23) and against DLB subjects with significant dopamine deficiency (n = 86). PCA was applied to test discrimination of patients with DLB from disease controls (n = 101) at individual patient level. RESULTS: Similar patterns of hypo- (parietal- and occipital cortex) and hypermetabolism (basal ganglia, limbic system, motor cortices) were observed in DLB patients with and without significant dopamine deficiency when compared to HC. Metabolic connectivity alterations correlated between DLB patients with and without significant dopamine deficiency (R2 = 0.597, p < 0.01). A PCA trained by DLB patients with dopamine deficiency and HC discriminated DLB patients without significant dopaminergic loss from other neurodegenerative parkinsonian disorders at individual patient level (area-under-the-curve (AUC): 0.912). CONCLUSION: Disease-specific patterns of altered glucose metabolism and altered metabolic networks are present in DLB subjects without significant dopaminergic loss. Metabolic network alterations in FDG-PET can act as a supporting biomarker in the subgroup of DLB patients without significant dopaminergic loss at symptoms onset.
引用
- Stockbauer A, Beyer L, Huber M, et al. Metabolic network alterations as a supportive biomarker in dementia with Lewy bodies with preserved dopamine transmission. Eur J Nucl Med Mol Imaging. 2023. PMID: 37971501. doi:10.1007/s00259-023-06493-w
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。